fbpx
A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

J&J Hard at Work on Additional COVID-19 Vaccines

0

Johnson & Johnson (J&J) is continuing to develop new COVID-19 vaccines to provide protection against a host of SARS-CoV-2 variants. Currently on the pharmaceutical giant’s agenda is creating a vaccine to combat the South African variant, B1351, which is more frequently found among young, healthy people and can cause more serious illness than the original strain of the novel coronavirus. A two-shot COVID-19 vaccine and boosters to its current one-shot immunization are also in the works. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy